Primary amyloidosis of urethra

Vasudevan, Parthasarathy; Stein, Avrum M.; Pinn, Vivian W.; Rao, Chadalawada N.

doi:10.1016/0090-4295(81)90234-x

Cited by 13 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the eight patients reported by Vasudevan et al . [17], five underwent transurethral resection, two underwent excision and perineal urethrostomy and one underwent anastomotic urethroplasty, but no outcomes were mentioned. Of the 40 patients reviewed by Crook et al .…”

Section: Discussionmentioning

confidence: 99%

What is the evidence for the management of urethral amyloidosis? A systematic review of the literature

Mangera¹,

Linton²,

Fernando

et al. 2011

BJU International

View full text Add to dashboard Cite

What's known on the subject? and What does the study add? Urethral amyloidosis is rare and urethrotomy has been proposed as a suitable treatment option. By reviewing the literature and comparing our own experiences, we have shown urethroplasty to have good medium term outcomes in patients with urethral amyloidosis, whereas urethrotomy may lead to recurrence. OBJECTIVE Urethral amyloidosis (UA) is a rare condition which may be encountered by an urological surgeon. We reviewed the literature regarding the presentation, investigation and management of UA. PATIENTS AND METHODS A systematic review of the English literature on PubMed was conducted and we indentified 39 articles which reported 45 patients. We included our experience with four patients from our tertiary centre. RESULTS The majority of patients reported symptoms consistent with a urethral structure. Most patients were treated with urethrotomy, only two patients have been reported to have had a urethroplasty in the literature. Medium and long term outcome data is lacking for urethrotomy and urethroplasty. We found recurrence in our patients after urethromoty and incomplete resection of UA. We describe short (6 month) and medium term (18 month) outcomes in two patients who underwent augmentation urethroplasty. CONCLUSION Although urethrotomy and dilatation have been proposed in the past, we found these may still lead to disease progression and therefore urethroplasty may be the most appropriate long term management option.

show abstract

Section: Discussionmentioning

confidence: 99%